Intesa Sanpaolo SpA.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Intesa Sanpaolo SpA.’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$633K	Buy	4,000 +2,000	+100%	+$270K	0.02%	145
2026 Q1	$255K	Sell	2,000 -3,350	-63%	-$418K	0.02%	163
2025 Q4	$651K	Buy	+5,350	New	+$613K	0.04%	137

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Intesa Sanpaolo SpA.'s XBI Position: Q2 2026 in Review

Intesa Sanpaolo SpA. increased its State Street SPDR S&P Biotech ETF (XBI) stake by 100% in Q2 2026, buying an estimated $270K and bringing the position to 4,000 shares worth $633K. The position accounts for 0.02% of the portfolio, ranked #145.

Intesa Sanpaolo SpA. first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. The position peaked at $651K in Q4 2025. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Intesa Sanpaolo SpA. held 4,000 shares of State Street SPDR S&P Biotech ETF worth $633K as of Q2 2026.
Intesa Sanpaolo SpA. bought 2,000 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $270K.
State Street SPDR S&P Biotech ETF made up 0.02% of Intesa Sanpaolo SpA.'s portfolio in Q2 2026, its #145 holding.
Intesa Sanpaolo SpA. first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
Intesa Sanpaolo SpA.'s State Street SPDR S&P Biotech ETF position peaked at $651K in Q4 2025.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Intesa Sanpaolo SpA.'s 13F filing for Q2 2026, filed 31 Jul 2026.